Improved prostate cancer treatment.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018849:Controlled Clinical Trials as Topic; D017373:Cyproterone Acetate / Q000627:therapeutic use*; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D014481:United States
D000726:Androgen Antagonists; D017273:Goserelin; D017373:Cyproterone Acetate